Skip to main content

Novo Nordisk

Novo Nordisk

Type

investor

Founded

1923

Funding Rounds

1

Portfolio companies

1

About Novo Nordisk

Novo Nordisk is a global healthcare company specializing in diabetes care, obesity, haemophilia, growth disorders and other chronic diseases. The company develops, manufactures and markets pharmaceutical products and devices, and invests heavily in R&D to advance therapies for metabolic and chronic conditions, partnering with research organisations and commercial channels globally to distribute treatments and support patient access.

Novo Nordisk investments captured (1)

Company NameStageTotal Deal AmountDate
UnknownundisclosedJun 23, 2026